Table 4.
Cure Prevalence (number and percentage of the complete prevalence) by cancer typea and years since diagnosis in Italy, 2018
| Cancer types | Cure Prevalence among patients alive since |
|||||
|---|---|---|---|---|---|---|
| ≥0 years |
≥5 years |
≥10 years |
||||
| Cure prevalence, n (%) | 1 – cure prevalence (%) | Cure prevalence, n (%) | 1 – cure prevalence (%) | Cure prevalence, n (%) | 1 – cure prevalence (%) | |
| Alltypesbut skinnon-melanoma | 2 865 749 (85.6) | 14.4 | 2 057 316 (93.0) | 7.0 | 1 372 262 (95.7) | 4.3 |
| Breast | 705 481 (87.5) | 12.5 | 525 209 (91.7) | 8.3 | 367 879 (94.7) | 5.3 |
| Prostate | 402 245 (94.1) | 5.9 | 262 341 (96.6) | 3.4 | 136 218 (98.0) | 2.0 |
| Colon–rectum | 381 496 (90.3) | 9.7 | 271 288 (97.3) | 2.7 | 172 444 (99.0) | 1.0 |
| Bladder | 222 412 (78.0) | 22.0 | 154 114 (84.5) | 15.5 | 99 985 (88.2) | 11.8 |
| Thyroid | 189 407 (99.3) | 0.7 | 134 826 (99.7) | 0.3 | 85 339 (99.8) | 0.2 |
| Skin melanoma | 165 450 (95.5) | 4.5 | 114 985 (98.9) | 1.1 | 77 119 (99.7) | 0.3 |
| Non-Hodgkin’s lymphoma | 134 581 (92.0) | 8.0 | 98 833 (98.2) | 1.8 | 67 140 (99.4) | 0.6 |
| Corpus uteri | 111 099 (91.3) | 8.7 | 83 999 (95.9) | 4.1 | 59 319 (97.6) | 2.4 |
| Kidney | 110 558 (80.4) | 19.6 | 79 226 (86.8) | 13.2 | 53 704 (90.1) | 9.9 |
| Lung | 56 342 (55.3) | 44.7 | 40 365 (88.9) | 11.1 | 24 975 (96.4) | 3.6 |
| Leukaemia | 79 708 (91.7) | 8.3 | 63 464 (98.9) | 1.1 | 47 912 (99.8) | 0.2 |
| Stomach | 67 903 (84.7) | 15.3 | 53 604 (97.9) | 2.1 | 40 040 (99.5) | 0.5 |
| Hodgkin’s lymphoma | 53 667 (94.8) | 5.2 | 45 274 (97.3) | 2.7 | 36 920 (98.4) | 1.6 |
| Testis | 53 248 (99.3) | 0.7 | 42 460 (99.8) | 0.2 | 32 703 (99.9) | 0.1 |
| Oral cavity | 34 232 (64.5) | 35.5 | 26 064 (78.8) | 21.2 | 17 827 (86.4) | 13.6 |
| Cervix uteri | 48 911 (93.1) | 6.9 | 42 406 (97.5) | 2.5 | 34 983 (98.6) | 1.4 |
| Ovary | 43 484 (83.4) | 16.6 | 35 532 (96.2) | 3.8 | 28 186 (99.1) | 0.9 |
| Soft-tissue sarcoma | 44 278 (88.0) | 12.0 | 35 790 (95.0) | 5.0 | 28 033 (97.5) | 2.5 |
| Larynx | 36 059 (74.4) | 25.6 | 28 296 (82.2) | 17.8 | 20 769 (87.3) | 12.7 |
| Brain and central nervous system | 30 508 (82.1) | 17.9 | 26 943 (96.2) | 3.8 | 23 697 (98.4) | 1.6 |
| Multiple myeloma | 14 999 (47.2) | 52.8 | 10 641 (66.6) | 33.4 | 6298 (78.7) | 21.3 |
| Liver | 8886 (28.0) | 72.0 | 6277 (55.1) | 44.9 | 3551 (72.2) | 27.8 |
| Pancreas | 9082 (48.6) | 51.4 | 5535 (96.9) | 3.1 | 2911 (99.8) | 0.2 |
| Bone | 12 088 (89.4) | 10.6 | 10 412 (95.7) | 4.3 | 8861 (98.0) | 2.0 |
| Vagina and vulva | 8067 (69.9) | 30.1 | 6067 (83.3) | 16.7 | 4353 (90.1) | 9.9 |
| Gallbladder | 6484 (61.1) | 38.9 | 4691 (91.9) | 8.1 | 3013 (97.5) | 2.5 |
| Small intestine | 8131 (87.0) | 13.0 | 5117 (97.4) | 2.6 | 2818 (99.4) | 0.6 |
| Oesophagus | 3221 (56.0) | 44.0 | 2362 (92.1) | 7.9 | 1556 (97.5) | 2.5 |
a
Cancer types with a prevalence of ≥10 per 100 000 are presented, sorted by the number of prevalent cases.